Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma

References

• ElseTKimACSabolchAAdrenocortical carcinomaEndocr Rev201435228232624423978
   PubMed Web of Science ®Google Scholar
• SidhuSSywakMRobinsonBDelbridgeLAdrenocortical cancer: recent clinical and molecular advancesCurr Opin Oncol2004161131814685087
   PubMed Web of Science ®Google Scholar
• HaraISakamotoYKanomataNLong-term survival after bilateral adrenalectomy for metachronous adrenocortical cancerInt J Urol200411121127112915663687
   PubMed Web of Science ®Google Scholar
• NCI [database on the Internet]SEER Incidence Data 1973–2015 (Including July-December 2005 Hurricane Katrina Impacted Louisiana Cases) Available from: http://seer.cancer.gov/index.htmlAccessed November 12, 2018
   Google Scholar
• KaplanELMeierPNonparametric estimation from incomplete observationsJ Am Stat Assoc195853282457481
   Web of Science ®Google Scholar
• MantelNEvaluation of survival data and two new rank order statistics arising in its considerationCancer Chemother Rep19665031631705910392
   PubMedGoogle Scholar
• CapitanioUJeldresCShariatSFKarakiewiczPClinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second bestEur Urol200854495895918485579
   PubMedGoogle Scholar
• KebebewEReiffEDuhQYClarkOHMcMillanAExtent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?World J Surg200630587287816680602
   PubMed Web of Science ®Google Scholar
• PatonBLNovitskyYWZereyMOutcomes of adrenal cortical carcinoma in the United StatesSurgery2006140691492017188138
   PubMed Web of Science ®Google Scholar
• SturgeonCShenWTClarkOHDuhQYKebebewERisk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?J Am Coll Surg2006202342343016500246
   PubMed Web of Science ®Google Scholar
• BerrutiABaudinEGelderblomHAdrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201223Suppl 7vii131vii13822997446
   PubMed Web of Science ®Google Scholar
• VeytsmanINiemanLFojoTManagement of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinomaJ Clin Oncol200927274619462919667279
   PubMed Web of Science ®Google Scholar
• SharmaEDahalSSharmaPThe characteristics and trends in adrenocortical carcinoma: a United States population based studyJ Clin Med Res201810863664029977421
   PubMedGoogle Scholar
• FassnachtMLibéRKroissMAllolioBAdrenocortical carcinoma: a clinician’s updateNat Rev Endocrinol20117632333521386792
   PubMed Web of Science ®Google Scholar
• WangSGaoWCChenSSPrimary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based databaseOnco Targets Ther2017105311531529184417
   PubMed Web of Science ®Google Scholar
• LuoYChenSSZhengXGLuoLWangSThe efficacy of radiation therapy in adrenocortical carcinoma: a propensity score analysis of a population-based studyMedicine20179617e674128445297
   PubMed Web of Science ®Google Scholar
• NilubolNPatelDKebebewEDoes lymphadenectomy improve survival in patients with adrenocortical carcinoma? A population-based studyWorld J Surg201640369770526510563
   PubMed Web of Science ®Google Scholar
• ZiniLCapitanioUJeldresCExternal validation of a nomogram predicting mortality in patients with adrenocortical carcinomaBJU Int2009104111661166719493261
   PubMed Web of Science ®Google Scholar
• KloosRTGrossMDFrancisIRKorobkinMShapiroBIncidentally discovered adrenal massesEndocr Rev19951644604848521790
   PubMed Web of Science ®Google Scholar
• MansmannGLauJBalkERothbergMMiyachiYBornsteinSRThe clinically inapparent adrenal mass: update in diagnosis and managementEndocr Rev200425230934015082524
   PubMed Web of Science ®Google Scholar
• ZiniLPorpigliaFFassnachtMContemporary management of adrenocortical carcinomaEur Urol20116051055106521831516
   PubMed Web of Science ®Google Scholar
• FassnachtMKreisslMCWeismannDAllolioBNew targets and therapeutic approaches for endocrine malignanciesPharmacol Ther2009123111714119374919
   PubMed Web of Science ®Google Scholar
• MillerBSDohertyGMSurgical management of adrenocortical tumoursNat Rev Endocrinol201410528229224637859
   PubMed Web of Science ®Google Scholar
• KirschnerLSThe next generation of therapies for adrenocortical cancersTrends Endocrinol Metab201223734335022626690
   PubMed Web of Science ®Google Scholar
• PolatBFassnachtMPfreundnerLRadiotherapy in adrenocortical carcinomaCancer2009115132816282319402169
   PubMed Web of Science ®Google Scholar
• HermsenIGGroenenYEDercksenMWTheuwsJHaakHRResponse to radiation therapy in adrenocortical carcinomaJ Endocrinol Invest2010331071271420220294
   PubMed Web of Science ®Google Scholar
• SabolchAFengMGriffithKHammerGDohertyGBen-JosefEAdjuvant and definitive radiotherapy for adrenocortical carcinomaInt J Radiat Oncol Biol Phys20118051477148420675074
   PubMed Web of Science ®Google Scholar
• TerzoloMAngeliAFassnachtMAdjuvant mitotane treatment for adrenocortical carcinomaN Engl J Med2007356232372238017554118
   PubMed Web of Science ®Google Scholar
• KutikovAEglestonBLWongYNUzzoRGEvaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogramJ Clin Oncol201028231131719933918
   PubMed Web of Science ®Google Scholar
• BrockmanJAAlaneeSVickersAJNomogram predicting prostate cancer-specific mortality for men with biochemical recurrence after radical prostatectomyEur Urol20156761160116725301759
   PubMed Web of Science ®Google Scholar
• International Bladder Cancer Nomogram ConsortiumBochnerBHKattanMWVoraKCPostoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancerJ Clin Oncol200624243967397216864855
   PubMed Web of Science ®Google Scholar
• WangSChenSSGaoWCPrognostic factors of adrenocortical carcinoma: an analysis of the surveillance epidemiology and end results (SEER) databaseAsian Pac J Cancer Prev201718102817282429072424
   PubMedGoogle Scholar
• XiaoWJZhuYDaiBConditional survival among patients with adrenal cortical carcinoma determined using a national population-based surveillance, epidemiology, and end results registryOncotarget2015642449554496226510907
   PubMedGoogle Scholar
• IasonosASchragDRajGVPanageasKSHow to build and interpret a nomogram for cancer prognosisJ Clin Oncol20082681364137018323559
   PubMed Web of Science ®Google Scholar